Insider · CIK 0001426651

Pavco Pamela

Reports to the SEC for 2 companies · WORCESTER, MA

sec.gov

Transactions

Companies

Filings

CIK

0001426651

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-02-01	PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award	Chief Development Officer	AAward	+7,000 sh	—	—	7,000
2016-12-16	PHIOPhio Pharmaceuticals Corp.A Award	Chief Development Officer	AAward	+11.1K sh	$0.90	+$9,999.9	17,173
2016-12-16	PHIOPhio Pharmaceuticals Corp. · Common stock warrantA Award	Chief Development Officer	AAward	+11.1K sh	—	—	11,111
2016-02-10	PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award	Chief Development Officer	AAward	+66K sh	—	—	66,000
2015-06-02	PHIOPhio Pharmaceuticals Corp.A Award	Chief Development Officer	AAward	+12.5K sh	$0.40	+$5,000	33,718
2015-06-02	PHIOPhio Pharmaceuticals Corp. · Overallotment purchase rightA Award	Chief Development Officer	AAward	+6,250 sh	—	—	6,250
2015-06-02	PHIOPhio Pharmaceuticals Corp. · Common stock purchase warrantA Award	Chief Development Officer	AAward	+6,250 sh	—	—	6,250
2015-06-01	PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award	Chief Development Officer	AAward	+66K sh	—	—	66,000
2013-06-07	PHIOPhio Pharmaceuticals Corp. · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+2M sh	—	—	2,000,000
2011-09-24	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Former VP Pharma Development	AAward	+150K sh	—	—	150,000
2011-03-15	SLSSELLAS Life Sciences Group, Inc.A Award	Former VP Pharma Development	AAward	+33.6K sh	—	—	44,940
2010-07-15	SLSSELLAS Life Sciences Group, Inc.A Award	Former VP Pharma Development	AAward	+5,000 sh	$2.38	+$11.9K	11,377
2010-04-15	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Former VP Pharma Development	AAward	+15K sh	—	—	15,000
2010-01-20	SLSSELLAS Life Sciences Group, Inc.A Award	Former VP Pharma Development	AAward	+6,377 sh	—	—	6,377
2010-01-14	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Former VP Pharma Development	AAward	+28.1K sh	—	—	28,054
2009-01-15	SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award	Former VP Pharma Development	AAward	+47K sh	—	—	234,137

Recent filings

Accepted (ET)
Feb 34
RXi Pharmaceuticals Corp0001209191-17-007724
SEC(opens sec.gov)
Dec 204
RXi Pharmaceuticals Corp0001209191-16-156235
SEC(opens sec.gov)
Feb 124
RXi Pharmaceuticals Corp0001209191-16-098329
SEC(opens sec.gov)
Jun 34
RXi Pharmaceuticals Corp0001209191-15-049287
SEC(opens sec.gov)
Jun 24
RXi Pharmaceuticals Corp0001209191-15-049135
SEC(opens sec.gov)
Jun 114
RXi Pharmaceuticals Corp0001181431-13-034210
SEC(opens sec.gov)
Sep 274
Pavco Pamela0001422882-11-000005
SEC(opens sec.gov)
Mar 174
Pavco Pamela0001209191-11-018781
SEC(opens sec.gov)
Jul 164
Pavco Pamela0001209191-10-038771
SEC(opens sec.gov)
Apr 164
Pavco Pamela0001209191-10-022648
SEC(opens sec.gov)
Jan 224
Pavco Pamela0001209191-10-004509
SEC(opens sec.gov)
Jan 194
Pavco Pamela0001209191-10-003649
SEC(opens sec.gov)
Jan 204
Pavco Pamela0001209191-09-003957
SEC(opens sec.gov)

Companies

Address

C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET

WORCESTER, MA, 01605